Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study93

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study57

Views

Views
June 202514
July 202518
August 20256
September 202510
October 20254
November 20255
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil17
Hong Kong10
United Kingdom7
South Africa3
Argentina1
Kenya1
Panama1
 

Top cities views

Views
Hong Kong10
Dallas4
Southwark2
Johannesburg2
Belo Horizonte1
Bom Jesus de Goiás1
Brasília1
Campina Grande1
Canarana1
Cape Town1